| Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study AJ Yarnall, DP Breen, GW Duncan, TK Khoo, SY Coleman, MJ Firbank, ... Neurology 82 (4), 308-316, 2014 | 498 | 2014 |
| Into the groove: can rhythm influence Parkinson's disease? C Nombela, LE Hughes, AM Owen, JA Grahn Neuroscience & Biobehavioral Reviews 37 (10), 2564-2570, 2013 | 452 | 2013 |
| Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study C Nombela, JB Rowe, SE Winder-Rhodes, A Hampshire, AM Owen, ... Brain 137 (10), 2743-2758, 2014 | 201 | 2014 |
| Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease Z Ye, E Altena, C Nombela, CR Housden, H Maxwell, T Rittman, ... Brain 137 (4), 1145-1155, 2014 | 138 | 2014 |
| Multiple modes of impulsivity in Parkinson's disease C Nombela, T Rittman, TW Robbins, JB Rowe PloS one 9 (1), e85747, 2014 | 138 | 2014 |
| Improving response inhibition in Parkinson’s disease with atomoxetine Z Ye, E Altena, C Nombela, CR Housden, H Maxwell, T Rittman, ... Biological Psychiatry 77 (8), 740-748, 2015 | 127 | 2015 |
| Cognitive rehabilitation in Parkinson’s disease: evidence from neuroimaging C Nombela, PJ Bustillo, PF Castell, L Sanchez, V Medina, MT Herrero Frontiers in neurology 2, 82, 2011 | 122 | 2011 |
| Atomoxetine restores the response inhibition network in Parkinson’s disease CL Rae, C Nombela, PV Rodríguez, Z Ye, LE Hughes, PS Jones, T Ham, ... Brain 139 (8), 2235-2248, 2016 | 110 | 2016 |
| Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson’s disease J Zhang, T Rittman, C Nombela, A Fois, I Coyle-Gilchrist, RA Barker, ... Brain 139 (1), 161-173, 2016 | 100 | 2016 |
| Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease DP Breen, C Nombela, R Vuono, PS Jones, K Fisher, DJ Burn, DJ Brooks, ... Movement Disorders 31 (7), 1062-1066, 2016 | 89 | 2016 |
| Predicting beneficial effects of atomoxetine and citalopram on response inhibition in P arkinson's disease with clinical and neuroimaging measures Z Ye, CL Rae, C Nombela, T Ham, T Rittman, PS Jones, PV Rodríguez, ... Human brain mapping 37 (3), 1026-1037, 2016 | 78 | 2016 |
| Personalized striatal targets for deep brain stimulation in obsessive-compulsive disorder JA Barcia, JM Avecillas-Chasín, C Nombela, R Arza, J García-Albea, ... Brain stimulation 12 (3), 724-734, 2019 | 73 | 2019 |
| Atomoxetine enhances connectivity of prefrontal networks in Parkinson’s disease RJ Borchert, T Rittman, L Passamonti, Z Ye, S Sami, SP Jones, ... Neuropsychopharmacology 41 (8), 2171-2177, 2016 | 66 | 2016 |
| Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose N Wolpe, J Zhang, C Nombela, JN Ingram, DM Wolpert, JB Rowe Scientific Reports 8 (1), 15643, 2018 | 42 | 2018 |
| How often does music and rhythm improve patients’ perception of motor symptoms in Parkinson’s disease? C Nombela, CL Rae, JA Grahn, RA Barker, AM Owen, JB Rowe Journal of Neurology 260, 1404-1405, 2013 | 34 | 2013 |
| Stimulation of the tractography-defined subthalamic nucleus regions correlates with clinical outcomes JM Avecillas-Chasin, F Alonso-Frech, C Nombela, C Villanueva, ... Neurosurgery 85 (2), E294-E303, 2019 | 30 | 2019 |
| Are we ready for cell therapy to treat stroke? FJ Rascón-Ramírez, N Esteban-García, JA Barcia, A Trondin, C Nombela, ... Frontiers in Cell and Developmental Biology 9, 621645, 2021 | 23 | 2021 |
| Time on timing: dissociating premature responding from interval sensitivity in Parkinson's disease J Zhang, C Nombela, N Wolpe, RA Barker, JB Rowe Movement Disorders 31 (8), 1163-1172, 2016 | 22 | 2016 |
| Alpha-theta effects associated with ageing during the stroop test C Nombela, M Nombela, P Castell, T García, J López-Coronado, ... PloS one 9 (5), e95657, 2014 | 22 | 2014 |
| The women neuroscientists in the cajal school E Giné, C Martínez, C Sanz, C Nombela, F De Castro Frontiers in Neuroanatomy 13, 72, 2019 | 19 | 2019 |
James RoweProfessor of Cognitive Neurology, Cambridge UniversityVerified email at mrc-cbu.cam.ac.uk
